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vided into improved group and exacerbation group. The following
clinical data and laboratory examinations were studied: ascites,
spontaneous bacterial peritonitis (SBP), alimentary tract hem-
orrhage, hepatocerebral disease, hepatorenal syndrome (HRS),
prothrombin time (PT), prothrombin time activity (PTA), Inter-
national ratio (INR), blood coagulation factor V (FV:C), ﬁbrino-
gen (FIB), D-dimer (D-D), total cholesterol (TC), total bilirubin
(TBIL), albumin (ALB), prealbumin (PRE-A), alanine aminotrans-
ferase (ALT), Blood urea (BUN), serum creatinine (SCR), blood
platelet (PLT). Analyze the index above with SPSS computer
software (SPSS version 12.0) by logistic regression for univariat
and multivariant analysis.
Results: Using logistic regression analysis, we found that: 1.
Ascites, SBP, hepatocerebral disease, PT, PTA, INR, FV:C, D-D,
TC, TBIL, PRE-A were signiﬁcantly different between the two
groups (P<0.05) in the univariat analysis; 2. TC, FV:C and ascites
were signiﬁcant risk factors for the prognosis of chronic hepatic
failure (P<0.05) in the multivariant analysis
Conclusion: TC, FV:C and ascites are valuable in predicting pa-
tients with chronic hepatic failure. A prognostic model: Y = 1/[1
+ exp(–s)], s = 191.13 – 34.81∗FV:C – 34.68∗TC – 35.22∗ascites
(Y means the possibility of patient’s death), was constructed by
logistic regression analysis.
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Objectives: To observe differences in speciﬁcity and stability of
speciﬁc cytotoxic T cells (CTL), and select the best experimental
conditions suitable for detection of HBV-speciﬁc CTL.
Methods: After HLA-A0201 and HLA-2402 allele-positive HBV-
infected persons were screened by high-resolution SSP-PCR;
PBMC of them were stained by different PE-labelled HBcAg epi-
tope peptide complex, PerCP Cy5.5-labelled mouse anti-human
CD3 monoclonal antibody and APC-labelled mouse anti-human
CD8 monoclonal antibody respectively. Except for T lympho-
cytes, other cells which may be combined with Pentamer were
removed by CD3 gating, comparing different kinds of added order
of three reagents and by the multi-parameter ﬂow cytometry
analysis.
Results: Frequencies of epitope-speciﬁc CTL from HBV-infected
persons who did not match HLA alleles were signiﬁcantly lower
than those of matched HLA alleles, P<0.05; Using the method
that MHC-Pentamer and test samples were coincubated for 20min
before adding CD3-PerCP Cy5.5 and CD8-APC which were coincu-
bated 20min later, frequencies of HBV-speciﬁc CTL were higher
than that of other groups, P<0.05; Frequencies of HBV-speciﬁc
CTL from CHB were signiﬁcantly lower than that of AHB, P<0.05.
Conclusion: If CTL epitopes and HLA alleles were matched, ratio
of speciﬁc CTL can be improved; Both CD3 monoclonal anti-
body and CD8 monoclonal antibody can prevent MHC-Pentamer
from combinating with the TCR, thereby frequencies of speciﬁc
CTL were reduced; Inadequate speciﬁc CTL of CHB may be one
important reasons for chronic infection.
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To evaluate the efﬁcacy of lamivudine treatment in patients with
acute-on-chronic liver failure (ACLF) and study the impact of HBV
DNA load and its related factors on the prognosis of patients with
acute-on-chronic liver failure (ACLF) after lamivudine treatment.
Methods: One hundred and thirty ACLF patients were treated
with lamivudine and the inﬂuential factors on mortality of pa-
tients were studied by univariate and multivariate analysis.
Results: The mortality (50.0%) of patients in lamivudine group
with MELD score from 30 to 40 was lower than that (86.1%) of
control group (χ2=23.319, P=0.000). The mortality of patients
with high virus load group (72/100, 72.0%) was higher than that
of low virus load group (15/30, 50.0%) (χ2=5.046, P=0.025). For
patients with MELD score from 30 to 40, by week 4 the mortality
of patients with HBV DNA undetectable or more than 2 log10
decline (2/13, 15.4%; 18/40, 45.0%) was lower than that of pa-
tients with less than 2 log10 decline (18/23, 78.3%) (χ2=15.328,
P=0.002). In multivariate analysis, in patients with MELD scores
30-40, treatment method (P=0.004), pretreatment HBV DNA load
(P=0.009), decline of HBV DNA load during therapy (P=0.014)
and encephalopathy (P=0.019) were independent predictors of
mortality; for MELD scores above 40, only MELD score (P=0.015)
was independent predictive.
Conclusions: Lamivudine treatment signiﬁcantly decreases the
3-month mortality of patients with MELD score 30-40, and a low
viral load pre-treatment and quick decline of HBV DNA load are
good predictors for the survival of lamivudine treatment.
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Background & Aims: We have reported that the genetic varia-
tion at the ESR1 locus inﬂuences susceptibility to persistent HBV
infection and HBV-related liver disease. However, further studies
are needed to determine whether the polymorphism (IVS1-401)
located in intron 1 is a regulatory polymorphism and clarify
its functional molecular mechanisms for this association with
chronic HBV infection and HBV-related diseases.
Methods: In a hospital-based case-control cohort composed of
359 HBV-related acute liver failure patients, 464 HBV-related
liver cirrhosis patients and 469 HBV asymptomatic carriers,
three polymorphisms (IVS1 T-401C, T29C, A11940G) of ESR1 gene
were analyzed using the polymerase chain reaction-restriction
fragment length polymorphism assay. Functional analyses were
conducted to verify the biological signiﬁcances of the associated
genetic variation.
Results:We found that the polymorphisms, T-401C and T29C, was
associated with susceptibility to HBV-ALF (dominant model; odds
ratio, 1.73; P=0.000) and HBV-LC (dominant model; odds ratio,
2.07; P=0.000). Functional analyses show that IVS1 T-401C poly-
morphism alters the binding afﬁnity of c-Myb and regulates ESR1
expression. The disease-susceptible allele, -401C, has stronger
ability to regulates ESR1 expression.
Conclusions: ESR1 IVS1 T-401C polymorphism is a cis-regultory
variant and -401C allele contributes to the risk of occurrence
of HBV-related liver failure and cirrhosis by binding c-Myb and
altering ESR1 exression
